OSU Center for Personalized Health Care Undertaking First Genetic Counseling Study on Heart Failure Patients

Investigators at the Center for Personalized Health Care at The Ohio State University Medical Center are currently recruiting patients with congestive heart failure (CHF) and hypertension (high blood pressure) for a study of the effects of genetic counseling on patients with chronic diseases. OSU is the first institution to involve heart patients in this study, which is being conducted as part of the Coriell Personalized Medicine Collaborative (CPMC).  The CMPC is a collaborative study among five leading health systems to determine whether personalized genetic information can be used to improve people’s health.

There are two primary goals of the study.  One is to determine whether genetic counseling, along with consistent support and follow through, will affect a patient’s willingness to initiate lifestyle changes. And secondly, the program hopes to educate physicians on the use of genomic information and implementing genetic counseling in everyday clinical practice.  

“Partnerships like the CPMC reinforce OSU Medical Center’s commitment to improving people’s lives through personalized health care,” says Dr. Steven Gabbe, Medical Center CEO. “When we can engage patients in their own health transformation, it is a tremendous help in providing them a higher quality of care and improving the cost-effectiveness of our outcomes.”

For full details and a video, see the release from OSU by clicking here.